14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening

Lancet

Volumn 353, Issue 9168, 1999, Pages 1903-1908

  Alexander, F E ^a   Anderson, T J ^a   Brown, H K ^a   Forrest, A P M ^a   Hepburn, W ^a   Kirkpatrick, A E ^b   Muir, B B ^b   Prescott, R J ^a   Smith, A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Scottish Bowel Screening Programme   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; SOCIAL STATUS; UNITED KINGDOM;

EID: 0033526560     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)07413-3     Document Type: Article

References (26)

1. Roberts MM, Alexander FE, Anderson TJ, et al. The Edinburgh randomised trial of screening for breast cancer: description of method. Br J Cancer 1984; 50: 1-6.
2. Roberts MM, Alexander FE, Anderson TJ, et al. Edinburgh trial of screening for breast cancer: mortality at seven years. Lancet 1990; 335: 241-46.
3. Alexander FE, Anderson TJ, Brown HK, et al. The Edinburgh Randomised Trial of Breast Cancer Screening: results after 10 years of follow-up. Br J Cancer 1994; 70: 542-48.
4. Alexander F, Roberts MM, Lutx W, Hepburn W. Randomisation by cluster and the problem of social class bias. J Epidemiol Community Health 1989; 93: 29-36.
5. Alexander FE, Brown H, Prescott RJ. Improved classification of socio-economic status explains differences in all-cause mortality in a randomised trial of breast cancer screening. J Epidemiol Biostat 1998; 3: 219-24.
6. Nyström L, Rutqvist LE, Wall S, et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 1993; 341: 973-78.
7. Shapiro S, Venet W, Strax P, Venet L, Roser R. Ten year to fourteen year effect of screening on breast cancer mortality. J Natl Cancer Inst 1982; 69: 349-55.
8. UK Breast Cancer Detection Working Group. Trial of early detection of breast cancer: description of method. Br J Cancer 1981; 44: 618-23.
9. UK Trial of Early Detection of Breast Cancer. 16-year mortality from breast cancer in the UK Trial of Early Detection of Breast Cancer. Lancet 1999; 353: 1909-14.
10. OPCS mortality statistics: cause. Series DH2 No 11. London: HMSO, 1985.
11. Williams DA. Extra-binomial variation in logistic linear models. ApplStat 1982; 31: 144-84.
12. Carstairs V, Morris R. Deprivation and health. BMJ 1989; 299: 1462.
13. Miller AB, Baines CJ, To T, Wall C. Canadian national breast screening study: 1. Breast cancer detection and death rates among women aged 40-49 years. Can Med Assoc J 1992; 147: 1459-76.
14. Miller AB, Baines CJ, To T, Wall C. Canadian national breast screening study: 2. Breast cancer detection and death rates among women aged 50-59 years. Can Med Assoc J 1992; 147: 1477-88.
15. Anders son I, Aspegren K, Janzon K, et al. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ 1988; 297: 943-48.
16. Tabár L, Chen HH, Faberberg G, Duffy SW, Smith TC. Recent results from the Swedish Two-County trial: the effects of age, histological type, and mode of detection on the efficiency of breast screening. J Natl Cancer Inst Monogr 1997; 22: 43-48.
17. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography. A meta-analysis. JAMA 1995; 273: 149-54.
18. National Institutes of Health Consensus Development Panel. National Institutes of Health Consensus Development Conference Statement: breast cancer screening for women ages 40-49, January 21-23, 1997. J Natl Cancer Inst 1997; 89: 1015-26.
19. Fletcher S. Breast cancer screening in women aged under 50. BMJ 1997; 314: 764-65.
20. Eastman P. NCI adopts new mammography screening guidelines for women. J Natl Cancer Inst 1997; 89: 538-40.
21. de Koning HJ, Boer R, Warmerdam PG, Beensterboer PMM, van der Maas PJ. Quantitative interpretation of age-specific mortality reduction from Swedish breast cancer-screening trials. J Natl CancerInst 1995; 87: 1217-23.
22. Alexander FE. Edinburgh randomised trial of breast cancer screening. J Natl Cancer Inst Monogr 1997; 22: 31-36.
23. Forrest APM. Breast cancer screening, report to the Health Ministers of England, Wales, Scotland and Northern Ireland by a working group. London: HMSO; 1987.
24. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Gröntoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 1992; 30: 187-210.
25. Alexander FE, Anderson TJ, Hubbard AL. Screening status in relation to biological and chronological characteristics of breast cancers: a cross-sectional survey. J Med Screen 1997; 4: 152-57.
26. Bjurstam N, Bjöneld J, Duffy SW, et al. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomisation. Cancer 1997; 80: 2091-99.